Curefit nets $145 mn at a valuation of $1.56 bn

The company has already approved the sale of 22.5 million Series F compulsorily convertible cumulative preference shares (CCPS) and one equity share at ₹483.62 for aggregate gross proceeds of ₹1,088.5 crore ($145 million)